News from edwards lifesciences corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Mar 06, 2023, 09:00 ET EDWARDS HIGHLIGHTS NEW DATA AT ACC RELATED TO LIFETIME MANAGEMENT OF AORTIC STENOSIS

Edwards Lifesciences (NYSE: EW) today highlighted new important data examining mortality rates and cardiac damage of early-stage aortic stenosis (AS) ...

Jan 31, 2023, 16:15 ET EDWARDS LIFESCIENCES REPORTS FOURTH QUARTER RESULTS

Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended December 31, 2022. Highlights and Outlook Q4 sales grew 1...

Jan 24, 2023, 07:05 ET EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON JANUARY 31, 2023

Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended December 31, 2022 after the market closes on Tuesday,...

Jan 05, 2023, 09:05 ET EDWARDS LIFESCIENCES TO PRESENT AT THE 41ST ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the J.P. Morgan Healthcare Conference on Tuesday, Jan. 10, 2023....

Dec 22, 2022, 08:00 ET EDWARDS LIFESCIENCES ANUNCIA DONACIONES POR MÁS DE $330 MIL A DIEZ ORGANIZACIONES BENÉFICAS EN COSTA RICA A TRAVÉS DE SU FUNDACIÓN

Dec 08, 2022, 08:01 ET EDWARDS LIFESCIENCES OUTLINES GROWTH STRATEGY AT ANNUAL INVESTOR CONFERENCE

Edwards Lifesciences Corporation (NYSE: EW) will discuss the company's strategy for longer-term growth, provide an update on its technology pipeline...

Dec 08, 2022, 08:00 ET EDWARDS LIFESCIENCES ANNOUNCES CEO SUCCESSION PLAN

Edwards Lifesciences Corporation (NYSE: EW) today announced that following regular succession planning discussions with the Board of Directors,...

Nov 27, 2022, 10:25 ET EDWARDS ANNOUNCES ONE-YEAR DATA ON TRANSFEMORAL TRANSCATHETER TRICUSPID VALVE REPLACEMENT

Edwards Lifesciences Corporation (NYSE: EW) announced that one-year results on patients treated in the single-arm, prospective, global, multi-center...

Nov 01, 2022, 09:00 ET EDWARDS LIFESCIENCES ANNOUNCES $750 MILLION ACCELERATED SHARE REPURCHASE

Edwards Lifesciences (NYSE: EW) today announced that it has executed an accelerated share repurchase agreement ("ASR") to repurchase $750 million of...

Oct 27, 2022, 16:15 ET EDWARDS LIFESCIENCES REPORTS THIRD QUARTER RESULTS

Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended September 30, 2022. Third Quarter Highlights and Outlook Q3...

Oct 20, 2022, 07:05 ET EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON OCTOBER 27, 2022

Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended September 30, 2022 after the market closes on Thursday, ...

Sep 17, 2022, 11:30 ET EDWARDS ANNOUNCES SIX-MONTH DATA CONFIRMING TEER AS SAFE AND EFFECTIVE FOR DMR IN FIRST HEAD-TO-HEAD TRIAL

Edwards Lifesciences Corporation (NYSE: EW) announced results from CLASP IID, the first randomized controlled trial that directly compares two...

Sep 15, 2022, 09:00 ET EDWARDS PASCAL PRECISION TRANSCATHETER VALVE REPAIR SYSTEM RECEIVES FDA APPROVAL FOR DEGENERATIVE MITRAL REGURGITATION

Edwards Lifesciences Corporation (NYSE: EW), today announced the company's PASCAL Precision transcatheter valve repair system for transcatheter...

Sep 12, 2022, 09:05 ET EDWARDS LAUNCHES SAPIEN 3 ULTRA RESILIA VALVE FOLLOWING FDA APPROVAL

Edwards Lifesciences (NYSE: EW) today announced the launch of the SAPIEN 3 Ultra RESILIA valve, which incorporates Edwards' breakthrough RESILIA...

Aug 17, 2022, 08:30 ET EDWARDS PASCAL PRECISION TRANSCATHETER MITRAL AND TRICUSPID VALVE REPAIR SYSTEM RECEIVES CE MARK

Edwards Lifesciences Corporation (NYSE: EW), today announced the company's PASCAL Precision transcatheter valve repair system received CE Mark for...

Jul 28, 2022, 16:15 ET EDWARDS LIFESCIENCES REPORTS SECOND QUARTER RESULTS

Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended June 30, 2022. Second Quarter Highlights and Outlook Q2 sales...

May 23, 2022, 08:10 ET EDWARDS LIFESCIENCES TO PRESENT AT THE BERNSTEIN 38TH ANNUAL STRATEGIC DECISIONS CONFERENCE

Edwards Lifesciences Corporation (NYSE: EW) today announced it is scheduled to present at the Bernstein 38th Annual Strategic Decisions Conference on ...

May 16, 2022, 09:15 ET EDWARDS ANNOUNCES KEY EVENTS FOR EUROPCR 2022

Edwards Lifesciences Corporation (NYSE: EW) announced key events for the company during EuroPCR 2022, the annual meeting of the European Association...

Apr 26, 2022, 16:15 ET EDWARDS LIFESCIENCES REPORTS FIRST QUARTER RESULTS

Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended March 31, 2022. First Quarter Highlights and Outlook Q1 sales...

Apr 19, 2022, 07:05 ET EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON APRIL 26, 2022

Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended March 31, 2022 after the market closes on Tuesday,...

Jan 26, 2022, 16:15 ET EDWARDS LIFESCIENCES REPORTS FOURTH QUARTER RESULTS

Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended December 31, 2021. Fourth Quarter Highlights and Outlook 2021...

Jan 19, 2022, 07:05 ET EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON JANUARY 26, 2022

Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended December 31, 2021 after the market closes on Wednesday, ...

Jan 05, 2022, 08:10 ET EDWARDS LIFESCIENCES TO PRESENT AT THE 40TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate at the J.P. Morgan Healthcare Conference on Monday, January 10, 2022. ...